Comprehensive metabolomics expands precision medicine for triple-negative breast cancerYi Xiao(Shanghai Medical College of Fudan University), Yi‐Zhou Jiang(Shanghai Medical College of Fudan University)Cell ResearchFebruary 1, 202210.1038/s41422-022-00614-0Cited by 315SaveCiteExport RISWatch citationsRelated PapersLncRNA TROJAN promotes proliferation and resistance to CDK4/6 inhibitor via CDK2 transcriptional activation in ER+ breast cancer|Molecular Cancer|2020|92PDSS1-Mediated Activation of CAMK2A-STAT3 Signaling Promotes Metastasis in Triple-Negative Breast Cancer|Cancer Research|2021|79